Horizon Therapeutics PLC (NASDAQ:HZNP)

88.03
Delayed Data
As of May 24
 +0.65 / +0.74%
Today’s Change
82.51
Today|||52-Week Range
120.54
-18.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues325.3M355.5M280.4M320.6M
 
 
 
 
 
Cost of Goods Sold29.8M40.5M29.3M30.0M
 
 
 
 
 
Depreciation And Amortization69.2M69.0M58.9M59.1M
 
 
 
 
 
 
Operating ExpensesGross Income226.3M246.0M192.2M231.5M
 
 
 
 
 
General Expenses181.3M194.3M194.0M195.4M
 
 
 
 
 
Research And Development21.2M19.7M21.7M28.3M
 
 
 
 
 
Total Operating Expenses280.3M303.8M282.2M284.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income45.0M51.7M-1.8M36.1M
 
 
 
 
 
Extraordinary Charge-3.1M-10.8M-5.6M-11.9M
 
 
 
 
 
Interest Expense On Debt30.4M29.8M27.5M22.0M
 
 
 
 
 
Other Expenses12.8M29.6M128.0K-12.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income24.3M40.7M-34.8M-10.0M
 
 
 
 
 
Income Taxes-1.7M-46.8M-1.9M-4.9M
 
 
 
 
 
Net Income26.0M87.6M-32.9M-5.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS167.0M168.1M172.8M185.3M
 
 
 
 
 
Shares To Calculate EPS Diluted172.5M174.2M172.8M185.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.15$0.50-$0.19-$0.03
 
 
 
 
 
EPS Diluted$0.15$0.50-$0.19-$0.03